vs
Side-by-side financial comparison of NORTECH SYSTEMS INC (NSYS) and Neuronetics, Inc. (STIM). Click either name above to swap in a different company.
Neuronetics, Inc. is the larger business by last-quarter revenue ($41.8M vs $30.3M, roughly 1.4× NORTECH SYSTEMS INC). NORTECH SYSTEMS INC runs the higher net margin — 3.0% vs -17.2%, a 20.2% gap on every dollar of revenue. On growth, Neuronetics, Inc. posted the faster year-over-year revenue change (85.7% vs 5.9%). NORTECH SYSTEMS INC produced more free cash flow last quarter ($5.5M vs $692.0K). Over the past eight quarters, Neuronetics, Inc.'s revenue compounded faster (54.9% CAGR vs -5.9%).
Nortech Systems Inc is a global electronics manufacturing services provider. It delivers end-to-end solutions covering product design, prototyping, full-scale production, and supply chain management for clients operating in medical technology, industrial automation, aerospace and defense, and transportation sectors. It specializes in high-reliability, regulatory-compliant electronic components and assemblies tailored to strict industry standards.
Neuronetics is a Malvern, PA based, publicly traded company incorporated in Delaware in April 2003, that develops non-invasive treatments for psychiatric disorders that have shown resistance or lack of improvement using traditional medicine. The treatments are based upon neuromodulation technology.
NSYS vs STIM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $30.3M | $41.8M |
| Net Profit | $897.0K | $-7.2M |
| Gross Margin | 16.7% | 52.0% |
| Operating Margin | 3.0% | -12.1% |
| Net Margin | 3.0% | -17.2% |
| Revenue YoY | 5.9% | 85.7% |
| Net Profit YoY | 160.7% | 43.2% |
| EPS (diluted) | $0.32 | $-0.10 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $30.3M | $41.8M | ||
| Q3 25 | $30.5M | $37.3M | ||
| Q2 25 | $30.7M | $38.1M | ||
| Q1 25 | $26.9M | $32.0M | ||
| Q4 24 | $28.6M | $22.5M | ||
| Q3 24 | $31.4M | $18.5M | ||
| Q2 24 | $33.9M | $16.4M | ||
| Q1 24 | $34.2M | $17.4M |
| Q4 25 | $897.0K | $-7.2M | ||
| Q3 25 | $-146.0K | $-9.0M | ||
| Q2 25 | $313.0K | $-10.1M | ||
| Q1 25 | $-1.3M | $-12.7M | ||
| Q4 24 | $-1.5M | $-12.7M | ||
| Q3 24 | $-739.0K | $-13.3M | ||
| Q2 24 | $157.0K | $-9.8M | ||
| Q1 24 | $765.0K | $-7.9M |
| Q4 25 | 16.7% | 52.0% | ||
| Q3 25 | 16.5% | 45.9% | ||
| Q2 25 | 15.8% | 46.6% | ||
| Q1 25 | 11.4% | 49.2% | ||
| Q4 24 | 9.9% | 66.2% | ||
| Q3 24 | 12.2% | 75.6% | ||
| Q2 24 | 13.6% | 74.0% | ||
| Q1 24 | 15.9% | 75.1% |
| Q4 25 | 3.0% | -12.1% | ||
| Q3 25 | 3.1% | -19.6% | ||
| Q2 25 | 2.4% | -21.1% | ||
| Q1 25 | -6.0% | -34.4% | ||
| Q4 24 | -4.3% | -51.0% | ||
| Q3 24 | -1.5% | -41.7% | ||
| Q2 24 | 1.0% | -51.7% | ||
| Q1 24 | 3.4% | -39.4% |
| Q4 25 | 3.0% | -17.2% | ||
| Q3 25 | -0.5% | -24.3% | ||
| Q2 25 | 1.0% | -26.6% | ||
| Q1 25 | -4.9% | -39.6% | ||
| Q4 24 | -5.2% | -56.4% | ||
| Q3 24 | -2.4% | -72.0% | ||
| Q2 24 | 0.5% | -59.8% | ||
| Q1 24 | 2.2% | -45.2% |
| Q4 25 | $0.32 | $-0.10 | ||
| Q3 25 | $-0.05 | $-0.13 | ||
| Q2 25 | $0.12 | $-0.15 | ||
| Q1 25 | $-0.48 | $-0.21 | ||
| Q4 24 | $-0.51 | $-0.34 | ||
| Q3 24 | $-0.27 | $-0.44 | ||
| Q2 24 | $0.05 | $-0.33 | ||
| Q1 24 | $0.26 | $-0.27 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.7M | $28.1M |
| Total DebtLower is stronger | — | $65.8M |
| Stockholders' EquityBook value | $34.5M | $22.4M |
| Total Assets | $71.9M | $141.6M |
| Debt / EquityLower = less leverage | — | 2.94× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.7M | $28.1M | ||
| Q3 25 | $1.3M | $28.0M | ||
| Q2 25 | $652.0K | $11.0M | ||
| Q1 25 | $1.2M | $20.2M | ||
| Q4 24 | $916.0K | $18.5M | ||
| Q3 24 | $1.2M | $20.9M | ||
| Q2 24 | $1.5M | $42.6M | ||
| Q1 24 | $4.0M | $47.7M |
| Q4 25 | — | $65.8M | ||
| Q3 25 | — | $65.7M | ||
| Q2 25 | — | $55.5M | ||
| Q1 25 | — | $55.3M | ||
| Q4 24 | — | $55.2M | ||
| Q3 24 | — | $46.0M | ||
| Q2 24 | — | $59.8M | ||
| Q1 24 | — | $59.4M |
| Q4 25 | $34.5M | $22.4M | ||
| Q3 25 | $33.4M | $27.4M | ||
| Q2 25 | $33.4M | $27.1M | ||
| Q1 25 | $32.8M | $35.5M | ||
| Q4 24 | $34.0M | $27.7M | ||
| Q3 24 | $35.7M | $9.4M | ||
| Q2 24 | $36.1M | $19.4M | ||
| Q1 24 | $36.0M | $27.7M |
| Q4 25 | $71.9M | $141.6M | ||
| Q3 25 | $74.8M | $145.5M | ||
| Q2 25 | $74.8M | $134.7M | ||
| Q1 25 | $73.5M | $142.0M | ||
| Q4 24 | $72.4M | $140.9M | ||
| Q3 24 | $77.0M | — | ||
| Q2 24 | $76.3M | $96.8M | ||
| Q1 24 | $75.5M | $103.8M |
| Q4 25 | — | 2.94× | ||
| Q3 25 | — | 2.40× | ||
| Q2 25 | — | 2.05× | ||
| Q1 25 | — | 1.56× | ||
| Q4 24 | — | 1.99× | ||
| Q3 24 | — | 4.90× | ||
| Q2 24 | — | 3.08× | ||
| Q1 24 | — | 2.15× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $5.6M | $908.0K |
| Free Cash FlowOCF − Capex | $5.5M | $692.0K |
| FCF MarginFCF / Revenue | 18.0% | 1.7% |
| Capex IntensityCapex / Revenue | 0.5% | 0.5% |
| Cash ConversionOCF / Net Profit | 6.25× | — |
| TTM Free Cash FlowTrailing 4 quarters | $2.1M | $-21.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $5.6M | $908.0K | ||
| Q3 25 | $-92.0K | $-785.0K | ||
| Q2 25 | $157.0K | $-3.5M | ||
| Q1 25 | $-2.9M | $-17.0M | ||
| Q4 24 | $793.0K | $-8.6M | ||
| Q3 24 | $-1.6M | $-5.4M | ||
| Q2 24 | $-4.3M | $-5.0M | ||
| Q1 24 | $2.8M | $-12.0M |
| Q4 25 | $5.5M | $692.0K | ||
| Q3 25 | $-242.0K | $-899.0K | ||
| Q2 25 | $58.0K | $-3.8M | ||
| Q1 25 | $-3.2M | $-17.2M | ||
| Q4 24 | $503.0K | $-8.7M | ||
| Q3 24 | $-1.6M | $-5.8M | ||
| Q2 24 | $-4.6M | $-5.6M | ||
| Q1 24 | $2.1M | $-12.4M |
| Q4 25 | 18.0% | 1.7% | ||
| Q3 25 | -0.8% | -2.4% | ||
| Q2 25 | 0.2% | -9.9% | ||
| Q1 25 | -11.9% | -53.8% | ||
| Q4 24 | 1.8% | -38.6% | ||
| Q3 24 | -5.2% | -31.3% | ||
| Q2 24 | -13.5% | -34.0% | ||
| Q1 24 | 6.1% | -71.1% |
| Q4 25 | 0.5% | 0.5% | ||
| Q3 25 | 0.5% | 0.3% | ||
| Q2 25 | 0.3% | 0.7% | ||
| Q1 25 | 1.0% | 0.7% | ||
| Q4 24 | 1.0% | 0.4% | ||
| Q3 24 | 0.1% | 2.1% | ||
| Q2 24 | 0.8% | 3.7% | ||
| Q1 24 | 2.2% | 2.2% |
| Q4 25 | 6.25× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.50× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -27.30× | — | ||
| Q1 24 | 3.70× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NSYS
| Medical Imaging | $11.4M | 37% |
| Medical Device | $8.0M | 26% |
| Industrial | $7.3M | 24% |
| Aerospace And Defense | $3.7M | 12% |
STIM
Segment breakdown not available.
